WallStSmart

Kellanova (K)vsSRx Health Solutions Inc. (SRXH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kellanova generates 135539% more annual revenue ($12.67B vs $9.34M). K leads profitability with a 10.1% profit margin vs 0.0%. K earns a higher WallStSmart Score of 50/100 (C-).

K

Buy

50

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 4.7Quality: 5.3
Piotroski: 5/9Altman Z: 2.20

SRXH

Avoid

19

out of 100

Grade: F

Growth: 2.7Profit: 3.0Value: 5.0Quality: 4.0
Piotroski: 2/9Altman Z: -4.74
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KSignificantly Overvalued (-235.2%)

Margin of Safety

-235.2%

Fair Value

$24.89

Current Price

$83.44

$58.55 premium

UndervaluedFair: $24.89Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

K1 strengths · Avg: 10.0/10
Return on EquityProfitability
32.1%10/10

Every $100 of equity generates 32 in profit

SRXH0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

K3 concerns · Avg: 2.7/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

PEG RatioValuation
3.632/10

Expensive relative to growth rate

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$36.08M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : K

The strongest argument for K centers on Return on Equity.

Bull Case : SRXH

SRXH has a balanced fundamental profile.

Bear Case : K

The primary concerns for K are Revenue Growth, PEG Ratio, EPS Growth.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 10.99 is elevated, increasing financial risk.

Key Dynamics to Monitor

K is growing revenue faster at 0.8% — sustainability is the question.

K generates stronger free cash flow (359M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

K scores higher overall (50/100 vs 19/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kellanova

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Kellogg Company, doing business as Kellogg's, is an American multinational food manufacturing company headquartered in Battle Creek, Michigan, United States.

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?